Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Roger

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
The Protein Journal|January 15, 2005
Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chainTakahiro Maruta, Behzod Z Dolimbek, K Roger Aoki, et al.
The Biochemical Journal|September 21, 2011
Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmissionGary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Immunobiology|February 2, 2011
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodiesM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
Journal of Psychosocial Nursing and Mental Health Services|March 18, 2014
Personality risk for alcohol consequences among college freshmenDonna M Kazemi, Claudia Flowers, Qiong Shou, et al.
Molecular Immunology|May 2, 2006
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/ABehzod Z Dolimbek, K Roger Aoki, Lance E Steward, et al.
Neuropharmacology|March 15, 2013
Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25Gary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Molecular Immunology|August 5, 2008
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatmentM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2006
Two protein trafficking processes at motor nerve endings unveiled by botulinum neurotoxin EGary Lawrence, Jiafu Wang, C K N Kwo Chion, et al.
Molecular Immunology|June 14, 2005
Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin AM Zouhair Atassi, Gulnoz S Dolimbek, Philip R Deitiker, et al.
Journal of Proteomics|August 19, 2025
Mining the plasma proteome: Evaluation of enrichment methods for depth and reproducibilityK Roger, I Metatla, S Ceccacci, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
The Protein Journal|January 15, 2005
Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chainTakahiro Maruta, Behzod Z Dolimbek, K Roger Aoki, et al.
The Biochemical Journal|September 21, 2011
Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmissionGary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Immunobiology|February 2, 2011
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodiesM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
Journal of Psychosocial Nursing and Mental Health Services|March 18, 2014
Personality risk for alcohol consequences among college freshmenDonna M Kazemi, Claudia Flowers, Qiong Shou, et al.
Molecular Immunology|May 2, 2006
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/ABehzod Z Dolimbek, K Roger Aoki, Lance E Steward, et al.
Neuropharmacology|March 15, 2013
Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25Gary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Molecular Immunology|August 5, 2008
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatmentM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2006
Two protein trafficking processes at motor nerve endings unveiled by botulinum neurotoxin EGary Lawrence, Jiafu Wang, C K N Kwo Chion, et al.
Molecular Immunology|June 14, 2005
Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin AM Zouhair Atassi, Gulnoz S Dolimbek, Philip R Deitiker, et al.
Journal of Proteomics|August 19, 2025
Mining the plasma proteome: Evaluation of enrichment methods for depth and reproducibilityK Roger, I Metatla, S Ceccacci, et al.
Pageof 8